Bioxcel Therapeutics is down a bit on the day, funds flowing out kept the price down -1.98% since yesterday.
Currently BTAI isn't at a clear support/resistance line that seems tradable. Bioxcel Therapeutics hasn't shown a lot of strength recently, shareholders don't seem that energized about the asset's future prospects. BTAI might find some support at the 1.01 level, buyers might push the price back up from here. But it's not very clear what will happen.